Results 201 to 210 of about 491,007 (324)
Development and usability testing of a preliminary web-based application for the clinical implementation of blood flow restriction: a mixed methods pilot study. [PDF]
Wedig IJ +4 more
europepmc +1 more source
Aggressive prostate cancer is associated with pericyte dysfunction
Tumor‐produced TGF‐β drives pericyte dysfunction in prostate cancer. This dysfunction is characterized by downregulation of some canonical pericyte markers (i.e., DES, CSPG4, and ACTA2) while maintaining the expression of others (i.e., PDGFRB, NOTCH3, and RGS5).
Anabel Martinez‐Romero +11 more
wiley +1 more source
Usability testing of EatsUp®: mobile application for monitoring balanced dietary practices and active lifestyle among adolescents-a study in Jakarta, Indonesia. [PDF]
Prafiantini E +7 more
europepmc +1 more source
Use of Selenastrum Capricornutum Growth Inhibition Test for Testing Toxicity of Metal Ions in Soil and Water [PDF]
Iliana Ivanova, V. Groudeva
openalex +1 more source
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard +12 more
wiley +1 more source
Genetic analysis of milk production traits of Tunisian Holsteins using random regression test-day model with Legendre polynomials [PDF]
Hafedh Ben Zaabza +2 more
openalex +1 more source
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang +8 more
wiley +1 more source
"My Back Exercise App"-mHealth for Low Back Pain: Development and Usability Testing. [PDF]
Comachio J +10 more
europepmc +1 more source
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard +5 more
wiley +1 more source

